Related Experiment Video
Updated: Mar 24, 2026

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
Published on: August 17, 2022
Preoperative cardiovascular investigations in liver transplant candidate: An update
Lalit Sehgal1, Piyush Srivastava2, Chandra Kant Pandey3
1Liver Transplant Anaesthesia and Critical Care (SICU), Rajiv Gandhi Cancer Institute and Research Centre, Rohini, New Delhi, India.
Insights
Cardiovascular complications are a significant risk for liver transplant recipients. This review examines evidence for diagnosing and stratifying cardiovascular risk in end-stage liver disease patients before transplantation.
Area of Science:
- Cardiology
- Hepatology
- Transplantation Medicine
Background:
- Cardiovascular complications significantly impact morbidity and mortality in end-stage liver disease (ESLD) patients undergoing liver transplantation.
- Ischemic heart disease is a primary contributor to these complications, necessitating thorough preoperative evaluation.
- ESLD patients often exhibit unique cardiovascular profiles, including high cardiac output and compromised ventricular function.
Purpose of the Study:
- To critically review the current evidence on diagnosing and risk-stratifying cardiovascular disorders in liver transplant candidates.
- To address the ongoing controversy regarding optimal screening methodologies for cardiovascular disease in this population.
Main Methods:
- Systematic review of the rapidly expanding body of evidence.
- Critical analysis of diagnostic and risk stratification strategies for cardiovascular disorders.
Main Results:
- Evidence suggests a need for comprehensive cardiovascular assessment in ESLD patients awaiting liver transplantation.
- Current screening methodologies show considerable controversy and require further refinement.
- Accurate risk stratification is crucial for optimizing patient outcomes.
Conclusions:
- Preoperative cardiovascular risk assessment is essential for improving outcomes in liver transplant recipients.
- Further research and consensus on screening methodologies are needed to effectively manage cardiovascular risks in ESLD patients.
- Optimizing the identification of high-risk candidates is paramount for successful liver transplantation.
Abstract:
Cardiovascular complications are a major cause of morbidity and mortality in patients with end-stage liver disease (ESLD) undergoing liver transplantation. Identifying candidates at the highest risk of postoperative cardiovascular complications is the cornerstone for optimizing the outcome. Ischaemic heart disease contributes to major portion of cardiovascular complications and therefore warrants evaluation in the preoperative period. Patients of ESLD usually demonstrate increased cardiac output, compromised ventricular response to stress, low systemic vascular resistance and occasionally bradycardia. Despite various recommendations for preoperative evaluation of cardiovascular disease in liver transplant candidates, a considerable controversy on screening methodology persists. This review critically focuses on the rapidly expanding body of evidence for diagnosis and risk stratification of cardiovascular disorder in liver transplant candidates.
Related Concept Videos
Kidney Transplant I: Introduction
Cardiac Catheterization I: Pre-Procedure Overview
Kidney Transplant II: Surgical Procedure
Imaging Studies for Cardiovascular System V: CT
Cardiomyopathy VII: Pre and Post Operative Nursing Management

